4th HIV Research for Prevention Conference (HIVR4P // Virtual)

Download All
January 27-28 and February 3-4, 2021
CCO is the official provider of online scientific analysis for HIVR4P 2021 through Capsule Summaries, downloadable slides, rapid expert Webinars, podcasts, and ClinicalThought commentaries.
Linda-Gail Bekker, MBChB, DTM&H, DCH, FCP(SA), PhD
Beatriz Grinsztejn, MD, PhD
Kenneth Mayer, MD

Capsule Summaries

Slidesets Phase IIb AMP Studies: In Vitro Susceptibility of HIV-1 Isolates to Broadly Neutralizing Antibody VRC01 Predicts HIV Prevention Efficacy in MSM, Transgender Persons, and Cisgender Women
Slidesets Preclinical Study of Biodegradable Implant Releasing TAF for Prevention of Vaginal SHIV Infection in Pigtailed Macaques
Slidesets HPTN 084: Long-Acting Injectable Cabotegravir Superior to Daily Oral TDF/FTC for HIV PrEP in Cisgender Women
Slidesets Islatravir Once Monthly for PrEP Demonstrates Favorable Safety/Tolerability and Meets Pharmacokinetic Threshold Target in Blinded Interim Analysis of Phase IIa Trial
Slidesets CAB LA Detectable in Plasma, Mucosal Tissue/Fluid Following Single IM Injection in Healthy Adults
Slidesets CONRAD 138 (ENRICH): Phase I Trial of Continuous or Interrupted 90-Day TFV/LNG Vaginal Ring in Women Without HIV
Slidesets Low Awareness of and Preference for Event-Driven PrEP Among US MSM
Slidesets PrEP-PP Observational Study: PrEP Initiation Among Pregnant and Postpartum Women in South Africa
Slidesets POWER: Most Diagnosed STIs Asymptomatic Among Adolescent Girls and Young Women Accessing PrEP Services as Part of Integrated Care in Johannesburg, South Africa
Slidesets AMPrEP: Transient Decline in PrEP/Condom Use, Sex With Casual Partners Among MSM During COVID-19 Restrictions in the Netherlands

ClinicalThought Commentaries

Read my take on promising new data from HIVR4P 2021 on monthly oral islatravir and injectable cabotegravir as long-acting PrEP options.

Beatriz Grinsztejn, MD, PhD Released: February 17, 2021

Read my take on promising new data from HIVR4P // Virtual 2021 on broadly neutralizing HIV antibody immunoprophylaxis and multipurpose prevention technologies under investigation for HIV prevention.

Kenneth Mayer, MD Released: February 18, 2021

Downloadable Slideset

In this downloadable slideset, CCO’s expert faculty members summarize key studies from this important conference, including clinical data on new PrEP options, implementation strategies, multipurpose prevention technologies, and an emerging treatment.

Linda-Gail Bekker, MBChB, DTM&H, DCH, FCP(SA), PhD Kenneth Mayer, MD Released: February 17, 2021

On Demand Webcasts

In this Webcast, Dr. Kenneth Mayer summarizes key studies from this important conference, including clinical data on new/emerging PrEP options, implementation strategies, and multipurpose prevention technologies.

Kenneth Mayer, MD Released: February 25, 2021

In this Webinar, Dr. Linda-Gail Bekker summarizes key studies from this important conference, including clinical data on new/emerging PrEP options, implementation strategies, and multipurpose prevention technologies.

Linda-Gail Bekker, MBChB, DTM&H, DCH, FCP(SA), PhD Released: March 1, 2021

Podcasts

Hear insights from Linda-Gail Bekker, MBChB, DTM&H, DCH, FCP(SA), PhD, on some of the most important new data reported at the 4th HIV Research for Prevention Conference (HIVR4P // Virtual), including results from studies evaluating novel approaches to HIV prevention such as broadly neutralizing antibodies, long-acting injectable and oral ARVs, implantable options, multipurpose prevention strategies, and key aspects of PrEP implementation

Linda-Gail Bekker, MBChB, DTM&H, DCH, FCP(SA), PhD Released: February 18, 2021

 

 

 

Conference organizers are using social media to communicate with delegates attending the meeting.

Social Media
Join the #HIVR4P conversation

Facebook, Twitter, Instagram, YouTube.

For more information about these resources and HIVr4P 2021, go to www.hivr4p.org.

NAM is the official provider of online scientific news reporter for the conference.

To view the coverage and to sign up for the bulletins, go to www.aidsmap.com/conference/hivr4P-2021.

Conference News – Reported by NAM

Provided by Clinical Care Options, LLC
Contact Info

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Produced in collaboration with
Educational grant provided by:
Gilead Sciences, Inc.
Janssen Therapeutics, Division of Janssen Products, LP
Merck Sharp & Dohme Corp.
ViiV Healthcare

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue